Recognizing and Managing Children with a Pediatric Cancer Predisposition Syndrome: A Guide for the Pediatrician

Pediatric Annals
Stephanie A CouryWen-Hann Tan

Abstract

It is estimated that at least 8% to 10% of children diagnosed with cancer have an inherited cancer predisposition syndrome. Pediatricians may be called upon to (1) identify children with symptoms suggestive of cancer that require further diagnostic testing, (2) identify children who should be referred to cancer genetics based on their personal and family histories, and (3) provide primary care to children who have an inherited cancer syndrome. This review article provides a list of clinical warning signs suggestive of childhood malignancy, discusses the personal and family history "red flags" suggestive of hereditary cancer, offers checklists to help identify patients who are candidates for cancer genetics evaluation, and describes features of the major pediatric cancer syndromes involving solid tumors and surveillance guidelines. This review aims to provide the pediatrician with the tools needed to recognize, refer, and help manage children at risk for pediatric cancer syndromes. [Pediatr Ann. 2018;47(5):e204-e216.].

References

Aug 24, 2004·Oncogene·Charles A Stiller
Jun 19, 2008·Journal of the National Cancer Institute. Monographs·Noralane M LindorUNKNOWN National Cancer Institute, Division of Cancer Prevention, Community Oncology and Prevention Trials Research Group
Feb 18, 2009·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Larry F EllisonUNKNOWN Canadian Cancer Society's Steering Committee for Canadian Cancer Statistics
Aug 19, 2011·Pediatric Blood & Cancer·Sara KnapkeKaren Burns
Nov 19, 2015·The New England Journal of Medicine·Jinghui ZhangJames R Downing
Jan 31, 2016·European Journal of Medical Genetics·Marjolijn C J JongmansNicoline Hoogerbrugge
Jan 4, 2017·Journal of the National Comprehensive Cancer Network : JNCCN·Mary B DalySusan Darlow
Mar 31, 2017·Journal of Genetic Counseling·Sarah ScollonKami Wolfe Schneider
Jun 3, 2017·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Garrett M BrodeurDavid Malkin
Jun 3, 2017·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Mary-Louise C GreerLisa J States
Jun 3, 2017·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Uri TaboriLaurence Brugières
Jun 3, 2017·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Christian P KratzDavid Malkin
Jun 18, 2017·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·D Gareth R EvansUri Tabori
Jun 18, 2017·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·William D FoulkesLisa Diller
Jun 18, 2017·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Surya P RednamJonathan D Wasserman
Jun 18, 2017·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Kris Ann P SchultzWilliam D Foulkes
Jul 5, 2017·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Harriet DrukerKami Wolfe Schneider
Jul 5, 2017·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Junne KamiharaGarrett M Brodeur
Jul 5, 2017·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Maria Isabel AchatzSharon E Plon
Jul 5, 2017·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jennifer M KalishTodd E Druley
Jul 5, 2017·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jonathan D WassermanJoshua D Schiffman
Dec 11, 2017·Journal of the National Comprehensive Cancer Network : JNCCN·Samir GuptaNdiya Ogba

❮ Previous
Next ❯

Citations

Sep 25, 2019·Cold Spring Harbor Perspectives in Medicine·Jaclyn Schienda, Jill Stopfer
Aug 11, 2021·Surgical Pathology Clinics·Jonathan C Slack, Alanna J Church

❮ Previous
Next ❯

Methods Mentioned

BETA
prophylactic surgery

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.